Muscle invasive bladder cancer: where is the field headed?

Pooja GhataliaJasmeet KaurGuru Sonpavde

Published in: Expert opinion on biological therapy (2023)

Biomarkers are urgently needed to identify appropriate treatment options for individual patients. The use of novel treatment approaches and biomarkers will help shape the future of precision therapy for MIBC and enable bladder preservation.

Keyphrases

muscle invasive bladder cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
spinal cord injury
prognostic factors
combination therapy
replacement therapy